Suppr超能文献

优化大肠大息肉切除术

Optimizing Resection of Large Colorectal Polyps.

作者信息

Heitman Steven J, Tate David J, Bourke Michael J

机构信息

Department of Medicine, University of Calgary, Calgary, AB, Canada.

Department of Gastroenterology and Hepatology, Westmead Hospital, c/-Suite 106a, 151-155 Hawkesbury Road, Westmead, Sydney, NSW, 2145, Australia.

出版信息

Curr Treat Options Gastroenterol. 2017 Mar;15(1):213-229. doi: 10.1007/s11938-017-0131-5.

Abstract

Polypectomy reduces the incidence and mortality of colorectal cancer (CRC). The widespread adoption of CRC screening, more rigorous colonoscopy techniques, and advancements in endoscopic imaging have led to a greater awareness of complex polyps. Whereas surgery was once considered necessary for many large sessile or laterally spreading lesions (LSLs) in the colorectum, the majority can now be removed endoscopically. Endoscopic mucosal resection (EMR) is an established technique for treatment of colorectal LSLs. When performed by experts, EMR is highly effective and safe and can be completed in an outpatient or day-stay setting. Advancements in EMR effectiveness encompass a better understanding of the factors leading to post-EMR recurrence, protocols to recognize and treat it, and interventions that prevent recurrent or residual adenoma. New techniques for treating intra-procedural bleeding and a novel classification system to identify and inform proactive management of deep mural injury enhance the safety profile of EMR. However, each of these incremental advancements necessitates a meticulous and systematic approach that only committed and properly trained endoscopists can master. While alternative interventions such as endoscopic submucosal dissection (ESD) offer potential advantages over EMR, the added procedural complexity, risks, and costs limit the relevance of ESD to a minority of lesions in the colorectum. This article reviews the expanding body of evidence supporting EMR as the first-line treatment of colorectal LSLs ≥20 mm.

摘要

息肉切除术可降低结直肠癌(CRC)的发病率和死亡率。CRC筛查的广泛应用、更严格的结肠镜检查技术以及内镜成像技术的进步,使人们对复杂息肉有了更高的认识。虽然手术曾被认为是治疗结直肠内许多大型无蒂或侧向扩散性病变(LSLs)的必要手段,但现在大多数此类病变都可以通过内镜切除。内镜黏膜切除术(EMR)是治疗结直肠LSLs的成熟技术。由专家实施时,EMR高效且安全,可在门诊或日间住院环境下完成。EMR有效性的进展包括对导致EMR后复发的因素有了更好的理解、识别和治疗复发的方案以及预防腺瘤复发或残留的干预措施。治疗术中出血的新技术以及用于识别和指导对深层壁层损伤进行积极管理的新分类系统提高了EMR的安全性。然而,这些渐进性进展中的每一项都需要一种细致且系统的方法,只有专注且经过适当培训的内镜医师才能掌握。虽然诸如内镜黏膜下剥离术(ESD)等替代干预措施相对于EMR具有潜在优势,但增加的操作复杂性、风险和成本限制了ESD仅适用于少数结直肠病变。本文综述了支持EMR作为直径≥20 mm结直肠LSLs一线治疗方法的越来越多的证据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验